HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

OSIR: Osiris Therapeutics Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
OSIRIS THERAPEUTICS INC (NASD)
OSIR 6.54 -0.03 (-0.46%) Vol.  163,479 15.00 CST

Nov 19, 2009 Osiris Therapeutics Down 17.8% Since SmarTrend's Sell Recommendation
Nov 12, 2009 Osiris Therapeutics Down 15.4% Since SmarTrend's Sell Recommendation
Nov 04, 2009 Osiris Therapeutics Reports Third Quarter 2009 Financial Results
Nov 04, 2009 Osiris Therapeutics Inc receives USD15m milestone payment from NuVasive
Nov 04, 2009 Osiris Therapeutics Inc receives USD15m milestone payment from NuVasive
Nov 03, 2009 OSIR: Achieves $15M Milestone Payment from NuVasive re Sales of Osteocel
Nov 03, 2009 Osiris Therapeutics Achieves $15 Million Milestone Payment
Oct 30, 2009 Integrity Media: Stem Cell Report Released
Oct 29, 2009 Osiris Therapeutics Down 21% Since SmarTrend's Sell Recommendation
Oct 26, 2009 BiomedReports: News and FDA Updates for Lpath (OTC:LPTN), Osiris (NASDAQ:OSIR)
Oct 23, 2009 xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 23, 2009 : GETI, OSIR, PHMD and ANPI
Oct 23, 2009 Osiris Therapeutics Announces Third Quarter 2009 Financial Results Conference Call
Oct 20, 2009 Osiris Therapeutics Down 13.3% Since SmarTrend's Sell Recommendation
Oct 13, 2009 Osiris Therapeutics (OSIR) Bearish Technical Alert - Trend Down 15.2%
Oct 06, 2009 Osiris Therapeutics Down 21.4% Since SmarTrend's Sell Recommendation
 
ZACKS COMMENTARY FOR OSIR
Nov 12, 2009 Zacks Blog: Osiris Posts Loss
Oct 30, 2009 Zacks Equity Research: Report for OSIR
Sep 09, 2009 Zacks Blog: Disappointment for Osiris
Jun 25, 2009 Zacks Blog: Still Positive on Osiris
May 07, 2009 Zacks Blog: Optimistic on Osiris
Apr 03, 2009 Industry Outlook: Pharmaceutical Industry
Mar 27, 2009 Zacks Blog: Osiris Setback in Phase III
Mar 26, 2009 Investment Ideas: Zacks Beats The Major Brokers
Mar 17, 2009 Zacks Blog: How to Spend $95 in Biotech
Feb 27, 2009 Zacks Blog: Options Trading in Biotech
Feb 12, 2009 Zacks Blog: Osiris' Prochymal Promising
Jan 15, 2009 Zacks Blog: Osiris: Double Good News

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research